Advancing Trial Delivery
Operational Excellence in Trial Execution
Point-of-Care, Remote, and Decentralized Models

SCOPE’s 16th Annual Advancing Trial Delivery stream showcases innovative models and strategies for improving the accessibility, efficiency, speed, and quality of clinical trials. This year’s program highlights several key drivers of change: expanding research into everyday healthcare settings through point-of-care solutions and partnerships, integrating flexible decentralized approaches and technologies into mainstream operations, scaling innovation strategies, and advancing eClinical capabilities to modernize operations. Case studies and discussions will address operational considerations, partnering strategies, and evidence-based approaches for improving participant experience while shortening trial timelines. 





Monday, March 1

SCOPE'S 6TH ANNUAL MASTERS OF CLINICAL RESEARCH GOLF TOURNAMENT

Golf Check-In & Breakfast Buffet

SCOPE's 6th Annual Masters of Clinical Research Golf Tournament (Sponsorship Opportunities Available)*

Network on the greens at SCOPE's 6th Annual Golf Tournament!  Visit the SCOPE website for player and sponsorship opportunities. 
*Limited space available. Must be registered for SCOPE. Separate registration and fee required.

PRE-CONFERENCE WORKSHOPS, USER GROUPS, & NETWORKING EVENTS (IN-PERSON ONLY)

– 3:00pm Evinova Workshop

See the Workshops & User Groups page for details.

– 3:45 pm SCOPE'S Pickleball Networking Session: Paddles & Partnerships

Kick off the SCOPE 2027 conference with food, fun, and pickleball! Whether you're a pickleball pro or have never picked up a paddle, this event is perfect for everyone. Limited spots available. See the Workshops & User Groups page for details.

– 3:30 IQVIA Innovation Day

See the Workshops & User Groups page for details.

– 3:30 MAXIS AI Workshop

See the Workshops & User Groups page for details.

Registration Open

Golf Lunch Buffet (Sponsorship Opportunities Available)

Close of the Masters of Clinical Research Golf Tournament

Monday Plenary Keynote Session

MONDAY OPENING PLENARY: PATIENTS, SITES & THE FUTURE OF CLINICAL RESEARCH

Grab Your Seat: Early-Bird Seat Golden Ticket Raffle & Prize Giveaway!*

*Must be present to win.

Organizer's Welcome Remarks & 6th Annual Masters of Clinical Research Golf Tournament Awards and Jacket Signing

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: SCOPE's 4th Annual Site Innovation Awards

Irfan Khan, CEO, Circuit Clinical , CEO , Circuit Clinical

Amanda Wright, Co-Founder & Senior Vice President, Healthcare Alliance, Javara , Co-Founder & SVP , Healthcare Alliance , Javara

Panelists:

Karen Correa, PhD, Vice President, Development Operations, Boehringer Ingelheim , Vice President , Clinical Development Operations , Boehringer Ingelheim

Angela DeLuca, Vice President, Global Head, Site Management & Monitoring, AstraZeneca , VP & Global Head Site Management & Monitoring , Site Management & Monitoring , AstraZeneca

Joe Dustin, Senior Director, Digital Clinical Development, Sanofi , Senior Director, Digital Clinical Development , Digital Clinical Development , Sanofi

Sean Soth, Senior Vice President, Strategy and Global Business Partnerships, SCRS , Senior Vice President , Society for Clinical Research Sites (SCRS)

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Kelly McKee, Vice President, Strategy & Transformation, Science 37; Co-Creator of the SCOPE Participant Engagement Award , Vice President, Strategy & Transformation , Science37

David Sall, President & CEO, Marketing, Patient Enrollment Advisors LLC; Co-Creator of the SCOPE Participant Engagement Award , President & CEO , Marketing , Patient Enrollment Advisors LLC

Panelists:

Andrea Bartucca, Director, Trial Awareness and Recruitment, Rapport Therapeutics , Director, Trial Awareness , Trial Awareness and Recruitment , Rapport Therapeutics

Sarah Bednarski, MS, Senior Director, Head Clinical Operations (ad interim), BlueRock Therapeutics , Sr. Director, Head Clinical Operations (ad interim) , Clinical Operations , BlueRock Therapeutics

Savine DaCosta, PhD, Clinical Trial Access and Representation Site Lead, Biogen , Clinical Trial Access and Representation Site Lead , Biogen

Anita Difrancesco, Senior Vice President, Clinical Operations, Endeavor Biomedicines , SVP , Clinical Operations , Endeavor Biomedicines

Gretchen Goller, Head, Recruitment and Retention, Pfizer Inc. , Head , Recruitment and Retention , Pfizer Inc.

April Lewis, Clinical Solutions, PatientPartner; Strategic Advisor, ZS , Sr. Director, Innovative Health , Global Development , Johnson & Johnson Innovative Medicine

Wendy Lurrie, Acting Head of Comms, BestGuessistan , Acting Head of Comms

Adrienne Walstrum, Senior Director, Global Trial Optimization, Merck , Senior Director , Global Trial Optimization , Merck & Co

Kate Wilson, Senior Director, Head of Global Clinical Trial Access & Representation, Biogen , Senior Director , Head of Global Clinical Trial Access & Representation , Biogen

KEYNOTE FIRESIDE CHAT: From Reform to Implementation: FDA’s New Clinical Trial Innovation Office and Operation Trialblazer

Kevin Bugin, PhD, Associate Vice President, Head, Global Regulatory Policy and Intelligence, Amgen , Head , Regulatory Policy and Intelligence , Amgen

Dianne Paraoan, Director, Office of Medical Policy, Office of New Drugs, CDER, FDA , Director , Office of Medical Policy, Office of New Drugs, CDER , FDA

FDA’s clinical-trial modernization agenda is moving from policy ambition to implementation. This plenary discussion will explore the new clinical-trial-innovation office being established within CDER’s Office of Medical Policy, Operation Trialblazer, and related FDA priorities. The conversation will focus on the office’s intended role, near-term priorities, opportunities to leverage existing industry capabilities, and what sponsors, sites, and research partners should anticipate as the work takes shape.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: Solving the Enrollment Crisis: Bridging Clinical Care and Clinical Research

Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine , Executive Director and Professor, Tufts Center for the Study of Drug Development. , Tufts University School of Medicine

Panelists:

Nikki Amaratunge, Vice President, Clinical Development Operations, Head of Clinical Site Management, AbbVie, Inc. , VP Clinical Dev Operations , Head of Clinical Site Management , AbbVie

Susan Griffing, Vice President, Late Development Oncology Clinical Operations, AstraZeneca , VP, Clinical Operations - Late Stage Oncology , Late Development Oncology Clinical Operations , AstraZeneca

Elizabeth Rogers, Vice President, Head, R&D Clinical Operations, Portfolio Development, CSL Behring , VP , Head, R&D Clinical Operations, Portfolio Development , CSL Behring

Melinda M. Rottas, Vice President, Head of Optimization, Analytics & Recruitment Solutions, Pfizer Inc. , VP, Head of Optimization , Analytics & Recruitment Solutions , Pfizer Inc

SCOPE's Kickoff Reception—Welcome to the Wild Wild West! (Sponsorship Opportunities Available)

Saddle up and kick off SCOPE the right way! Reunite with friends, make new connections, and soak up the Florida vibes at a Wild Wild West showdown you won't want to miss.

Close of Day

Tuesday, March 2

TUESDAY MORNING EXERCISE & COFFEE

Sunrise Yoga: In Gratitude for Clinical Research Participants

Start your day with movement, mindfulness, and gratitude. Join us at sunrise for an all-levels yoga session honoring the invaluable contributions of clinical research participants. Led by a trained instructor, this restorative practice will focus on mindful movement, breath, and grounding—no experience necessary. Yoga begins at 6:30 am; mats and towels are provided.
Stay afterward for a complimentary breakfast and fitness-inspired gift! Proceeds from this event help support CISCRP's mission. 

Registration Link Coming Soon!

SCOPE's 5K Rise and Shine Fun Run! (Sponsorship Opportunities Available)

Lace up and start your SCOPE day on the move! Join SCOPE's Coordinators for the 5K Rise and Shin Fun Run/Walk. Run, jog, walk, or chat your way through the course—ALL abilities are welcome. It's a fun, informal way to get moving and connect with fellow attendees. Full details to come, so don't forget your sneakers! 

Registration Open

Get Up and Go Specialty Coffee (Sponsorship Opportunities Available)

Start your day with a little extra fuel! Grab made-to-order specialty coffee and sweet bites, courtesy of our sponsors.

Tuesday Morning Opening Plenary Keynotes

TUESDAY PLENARY: RETHINKING THE SPEED AND SHAPE OF CLINICAL DEVELOPMENT

Grab Your Seat—Early Bird Seat Raffle & Prize Giveaway!* (Sponsorship Opportunity Available)

Arrive early and you could leave a winner! Grab your seat and enter SCOPE’s Early Bird Seat Raffle for a chance to win an exciting prize. Don’t be late—*Must be present to win!

Welcome to SCOPE Europe 2027—Saddle up for the Future of Clinical Trials

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

KEYNOTE FIRESIDE CHAT: The Other Side of Drug Development: Pharma Leader's Journey as a Rare Disease Parent

Craig Lipset, Founder, Advisor, Clinical Innovation Partners; Co-Chair, Decentralized Trials & Research Alliance (DTRA) , Co Chair , Decentralized Trials & Research Alliance DTRA

Casey McPherson, CEO and Founder, AlphaRose Therapeutics , CEO and Founder , AlphaRose Therapeutics

Michelle Werner, Executive Vice President & President North America, Ipsen; Rare Disease Mom and Advocate , EVP , President, North America , Ipsen

For leaders who have spent their careers developing medicines, the experience of navigating a rare disease within their own family can bring an entirely different perspective to the urgency, complexity, and human impact of drug development. This fireside conversation will explore that intersection: what changes when an industry leader experiences drug development and clinical research as a parent, what the industry can learn from that perspective, and how it can inform the way we develop medicines and design clinical trials for patients and families.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible?

Micky Cohen-Wolkowiez, MD, PhD, Executive Director, i-Cubed, Duke Clinical Research Institute , i-Cubed Executive Director , Duke Clinical Research Institute

Panelists:

Meghana Chalasani, Associate Director for Clinical Trial Innovation, Office of New Drugs, FDA CDER , Associate Director for Clinical Trial Innovation , Office of New Drugs , FDA CDER

Zhanna Jumadilova, MD, Biopharmaceutical Physician Executive, Pragmatic Clinical Trials, R&D, Pfizer Inc. , Pragmatic Trials Clinical Lead , Pragmatic Clinical Trials, R&D , Pfizer

Christoph Koenen, MD, Head of Clinical Development & Operations, Pharma R&D, Bayer , Head of Clinical Development & Operations , Pharma Research & Development , Bayer

Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences , SVP Clinical Data Science , Clinical Data Science , Gilead Sciences

Michelle Werner, Executive Vice President & President North America, Ipsen; Rare Disease Mom and Advocate , EVP , President, North America , Ipsen

Grand Opening Coffee & Refreshment Break in the Exhibit Hall —Best of Show Voting Opens

Step into SCOPE’s one-of-a-kind exhibit hall! With 300+ leading clinical trial technology and service companies, it’s the place to discover new partners and reconnect with familiar ones. Cast your vote for SCOPE’s Best of Show, recharge with coffee, snap a photo, and don’t forget your comfy shoes—you’ll have miles to explore!

Part 1: Operational Excellence in Trial Execution

Tuesday AM Tracks

RETHINKING TRIAL PLANNING AND EXECUTION

Smart Design and Intelligent Technology—An Answer to the Clinical-Trial Crisis

Photo of Martin J. Landray, FMedSci, CEO, Protas , Chief Executive Officer , Protas
Martin J. Landray, FMedSci, CEO, Protas , Chief Executive Officer , Protas

Drug discovery is booming but the clinical-trial system is failing. Whilst data, technology, and AI tooling transforms other complex, safety-focused, and highly regulated industries (from banking to aviation), clinical trials are stuck with digital replicas of analogue processes. The fusion of smart design and intelligent technology offers solutions across the trial lifespan from data-led design, through operational planning and execution, quality management and medical oversight, to analysis and reporting. Previous trials will be used to demonstrate the opportunity for a new era of clinical-trial speed, cost, quality, and predictability in a variety of late-phase development settings.

Faster Answers, Persistent Uncertainty, Rethinking Trial Planning

Photo of Kasia Harris, MD, Country & Feasibility Head, COQSCD Site Activation & Business Management, Astellas Pharma, Inc. , Country & Feasibility Head , COQSCD Site Activation & Business Management , Astellas Pharma Inc
Kasia Harris, MD, Country & Feasibility Head, COQSCD Site Activation & Business Management, Astellas Pharma, Inc. , Country & Feasibility Head , COQSCD Site Activation & Business Management , Astellas Pharma Inc

Many decisions that shape trial delivery are made before the first site opens. Technology makes it easier to turn information into answers, but an answer doesn't tell us what's missing or what could change the plan. This session explores how we question assumptions, assess risk, apply context, and communicate what matters. As our tools evolve, so must the conversation we have with technology.

Panel Moderator:

PANEL DISCUSSION:
Trial Acceleration and Timeline Compression

Photo of Robert Goodwin, COO, Parexel , Chief Operating Officer , Parexel
Robert Goodwin, COO, Parexel , Chief Operating Officer , Parexel

Panelists:

Photo of David Carruthers, Vice President, BioPharmaceuticals R&D Clinical Operations, AstraZeneca , Vice President , BioPharmaceuticals R&D Clinical Operations , AstraZeneca
David Carruthers, Vice President, BioPharmaceuticals R&D Clinical Operations, AstraZeneca , Vice President , BioPharmaceuticals R&D Clinical Operations , AstraZeneca
Photo of Natalie Fishburn, Global Head, Global Clinical Operations, Novartis AG , EVP and Head, Global Clinical Operations , Global Clinical Operations , Novartis Pharma AG
Natalie Fishburn, Global Head, Global Clinical Operations, Novartis AG , EVP and Head, Global Clinical Operations , Global Clinical Operations , Novartis Pharma AG

Sponsored Networking Luncheon

Recharge, refuel, and connect over lunch—compliments of SCOPE sponsors! Enjoy a well-deserved break.

Networking Coffee & Dessert Break in the Exhibit Hall

Keep the conversations going in the Exhibit Hall with coffee and dessert, courtesy of SCOPE sponsors. Network with colleagues, explore new products and services, and don’t forget—Best of Show Award voting is still open, so be sure to cast your vote!

Tuesday PM Tracks

NOVEL OPERATING MODELS AND INNOVATION MANAGEMENT

Study Optimization: Building a Data-Driven Trial Delivery Organization in Mid-Sized Biopharma

Photo of Nicole Turner, Senior Director, Head, Study Optimization, Daiichi Sankyo , Senior Director, Head , Study Optimization , Daiichi Sankyo
Nicole Turner, Senior Director, Head, Study Optimization, Daiichi Sankyo , Senior Director, Head , Study Optimization , Daiichi Sankyo

As clinical development continues to evolve, mid-sized biopharma companies face increasing pressure to accelerate trial delivery while operating with lean internal teams and relying on outsourced execution through CRO partners. In this environment, providing oversight is not enough. We must transform how decisions are made throughout study planning and execution. 

This session explores the evolution of the study optimization in an organization that connects feasibility, country and site strategy, patient recruitment, trial diversity and functional excellence. Attendees will learn how one mid-sized biopharma is re-designing its operating model to strengthen internal capabilities, improve governance, and create greater consistency in study planning without increasing operational complexity. 

The presentation will share practical approaches to embedding functional excellence into Global Clinical Operations, modernizing country and site distribution strategies through technology-enabled planning, strengthening oversight in a fully outsourced model, and fostering a culture that focuses on data, cross-functional collaboration, and continuous improvement. Real-world examples will illustrate how organizational design, process optimization, and strategic use of data can drive more informed decisions during trial planning.

Scaling from Pilot to Portfolio

Photo of Kelly Morris, Director, Patient Recruitment & Clinical Innovation, AstraZeneca , Director, Patient Recruitment , Patient Recruitment & Clinical Innovation , AstraZeneca
Kelly Morris, Director, Patient Recruitment & Clinical Innovation, AstraZeneca , Director, Patient Recruitment , Patient Recruitment & Clinical Innovation , AstraZeneca
Photo of Michele Teufel, Senior Director, Therapy Area Strategy & Portfolio Delivery, SM&M, AstraZeneca , Senior Director, Therapy Area Strategy & Portfolio Delivery , Clinical Operations , AstraZeneca Pharmaceuticals Inc
Michele Teufel, Senior Director, Therapy Area Strategy & Portfolio Delivery, SM&M, AstraZeneca , Senior Director, Therapy Area Strategy & Portfolio Delivery , Clinical Operations , AstraZeneca Pharmaceuticals Inc

Sustainable improvements in recruitment and retention require moving beyond study-by-study planning to a more connected portfolio approach. By leveraging disease area insights, shared evidence, and standardized capabilities, organizations can create a consistent foundation that supports study-level execution while enabling targeted interventions based on patient population, protocol complexity, geography, and enrollment risk. Integrating patient experience, site readiness, operational delivery, and performance monitoring creates a scalable framework that accelerates enrollment, improves retention, and drives continuous learning across programs. This approach enables greater consistency, efficiency, and adaptability throughout the clinical development lifecycle.

Reimagining Clinical Trial Recruitment: Reaching Patients Where They Are

Photo of John Campbell, Head of Decentralized Trials, Walgreens Co. , Head of Decentralized Trials , Walgreen Co.
John Campbell, Head of Decentralized Trials, Walgreens Co. , Head of Decentralized Trials , Walgreen Co.

Most trials fall behind because eligible patients never learn research exists. Walgreens is changing that by using national patient reach and relationships to identify, reach, and activate potential research participants. This session covers what that model has delivered, where it works, and what it takes to operationalize at scale.

Welcome Reception in the Exhibit Hall

Raise a glass and celebrate Day 1 of SCOPE! Reconnect with friends, meet new colleagues, and enjoy drinks with exhibitors at the Welcome Reception in the Exhibit Hall. Enter to win fabulous raffle prizes (must be present to win), then keep the evening going with dinner at Rosen Shingle Creek’s restaurants—no Orlando traffic required!

Close of Day

SCOPE Out the Restaurants and Shops at Pointe Orlando, via Our Courtesy Shuttle* (Sponsorship Opportunities Available)

Enjoy an evening exploring the restaurants and shops at Pointe Orlando with transportation provided by our courtesy shuttle. Shuttles will run until 11:00 pm, with the last pick-up at 10:30 pm.

*Times subject to change. More details closer to the event.​

Wednesday, March 3

Sunrise Yoga: In Gratitude for Clinical Research Participants

Start your day with movement, mindfulness, and gratitude. Join us at sunrise for an all-levels yoga session honoring the invaluable contributions of clinical research participants. Led by a trained instructor, this restorative practice will focus on mindful movement, breath, and grounding—no experience necessary. Yoga begins at 6:30am; mats and towels are provided. Stay afterward for a complimentary breakfast and fitness-inspired gift!  Proceeds from this event help support CISCRP's mission. 

Registration Link Coming Soon!

Registration Open

Wednesday Sponsored Breakfasts

BREAKFAST PRESENTATIONS

– 9:00 am In-Person Only Working Group Breakfast (Invitation Only)

Transition to Sessions

Wednesday AM Tracks

OPERATIONALIZING AI-POWERED TRIAL DELIVERY

Quantifying the Financial Value Created by Agentic AI-Supported Study Monitoring

Photo of Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine , Executive Director and Professor, Tufts Center for the Study of Drug Development. , Tufts University School of Medicine
Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine , Executive Director and Professor, Tufts Center for the Study of Drug Development. , Tufts University School of Medicine

This session reviews the results of a first-of-its-kind new study quantifying the return on investment (ROI) in, and the net financial value created by, an agentic AI study monitoring solution. Based on hard data drawn from industry benchmarks and actual experience, the Tufts CSDD research team quantified the financial value associated with efficiencies gained from improvements in onsite study monitoring capacity and workload, reductions in onsite monitor travel-related costs, as well as efficiencies gained from improvements in remote administrative monitoring activities.

Panel Moderator:

PANEL DISCUSSION:
Organizational Readiness for Tech-Enabled Trial Delivery

Photo of Michele Sausser, Vice President, Clinical Excellence and Innovation, Vaccines, Vaccines Research and Development, Pfizer Inc. , Vice President, Clinical Excellence and Innovation, Vaccines , Vaccines Research and Development , Pfizer Inc.
Michele Sausser, Vice President, Clinical Excellence and Innovation, Vaccines, Vaccines Research and Development, Pfizer Inc. , Vice President, Clinical Excellence and Innovation, Vaccines , Vaccines Research and Development , Pfizer Inc.

Panelists:

Photo of Kasia Harris, MD, Country & Feasibility Head, COQSCD Site Activation & Business Management, Astellas Pharma, Inc. , Country & Feasibility Head , COQSCD Site Activation & Business Management , Astellas Pharma Inc
Kasia Harris, MD, Country & Feasibility Head, COQSCD Site Activation & Business Management, Astellas Pharma, Inc. , Country & Feasibility Head , COQSCD Site Activation & Business Management , Astellas Pharma Inc

Erin Moeller, Executive Director, Clinical Data Management, Merck , Executive Director , Clinical Data Management , Merck

Photo of Alex Simmonds, Global Drug Development Innovation Lead, R&D, Bristol Myers Squibb Co. , Global Drug Development Innovation Lead , R&D , Bristol Myers Squibb Co
Alex Simmonds, Global Drug Development Innovation Lead, R&D, Bristol Myers Squibb Co. , Global Drug Development Innovation Lead , R&D , Bristol Myers Squibb Co

Coffee Break in the Exhibit Hall (Sponsorship Opportunities Available)

Refuel, reconnect, and make the most of your time in the Exhibit Hall! Grab a cup of coffee, visit booths you haven’t explored, and connect with colleagues and exhibitors. It’s your final chance to cast your vote for SCOPE’s Best of Show Award—make your vote count!

Part 2: Point-of-Care, Remote, and Decentralized Models

Wednesday Mid AM Tracks

FROM INTERNAL SILOS TO EXTERNAL PARTNERSHIPS

Panel Moderator:

PANEL DISCUSSION:
Cross-Functional Collaboration and Team Alignment

Photo of Kerstin Koenig, PhD, Vice President, R&D Quality and Risk Management (QuRE), GlaxoSmithKline , Vice President, R&D Quality and Risk Management (QuRE) , GSK
Kerstin Koenig, PhD, Vice President, R&D Quality and Risk Management (QuRE), GlaxoSmithKline , Vice President, R&D Quality and Risk Management (QuRE) , GSK

Panelists:

Photo of Melissa Binz, Vice President, Head Development & Chief Medical Office Digital and Technology, Bristol Myers Squibb , Vice President, Drug Development Data and Agentic Operations , Bristol Myers Squibb
Melissa Binz, Vice President, Head Development & Chief Medical Office Digital and Technology, Bristol Myers Squibb , Vice President, Drug Development Data and Agentic Operations , Bristol Myers Squibb
Photo of Cheryl A. Grandinetti, PharmD, Associate Director for Clinical Policy, Office of Scientific Investigations, Division of Clinical Compliance Evaluation (DCCE), CDER, FDA , Associate Director for Clinical Policy , FDA
Cheryl A. Grandinetti, PharmD, Associate Director for Clinical Policy, Office of Scientific Investigations, Division of Clinical Compliance Evaluation (DCCE), CDER, FDA , Associate Director for Clinical Policy , FDA
Photo of Ann Meeker-O'Connell, Executive Director, Monitoring Excellence Head, Novartis , Executive Director, Monitoring Excellence Head , Novartis
Ann Meeker-O'Connell, Executive Director, Monitoring Excellence Head, Novartis , Executive Director, Monitoring Excellence Head , Novartis

Panel Moderator:

PANEL DISCUSSION:
Becoming the Sponsor of Choice: What Sites Really Want from Their Industry Partners

Photo of Caroline Feys, MSc, MBA, Senior Director Innovative Health, J&J Innovative Medicine , Sr. Director Innovative Health , Innovative Health , Johnson & Johnson Innovative Medicine
Caroline Feys, MSc, MBA, Senior Director Innovative Health, J&J Innovative Medicine , Sr. Director Innovative Health , Innovative Health , Johnson & Johnson Innovative Medicine

Panelists:

Photo of Terttu Haring, MD, Executive Director, Johnson & Johnson Innovative Medicine , Executive Director , Johnson & Johnson Innovative Medicine
Terttu Haring, MD, Executive Director, Johnson & Johnson Innovative Medicine , Executive Director , Johnson & Johnson Innovative Medicine

Sponsored Networking Luncheon

Recharge, refuel, and connect over lunch—compliments of SCOPE sponsors! Enjoy a well-deserved break.

Networking Coffee & Dessert Break in the Exhibit Hall (Sponsorship Opportunities Available)—Best of Show Winner to be Announced

Recharge, reconnect, and satisfy your sweet tooth! Grab coffee and a treat, courtesy of our sponsors, then visit Game Card Sponsors to collect stickers and connect with colleagues before the afternoon sessions.  And don't miss the big reveal-the Best of Show winner will be announced during the break!

Wednesday PM Tracks

PARTNERING WITH HEALTHCARE SYSTEMS AND SITE NETWORKS

Panel Moderator:

PANEL DISCUSSION:
Unlocking Value through Strategic Partnerships with Health Systems and Site Networks

Photo of Renee Smith, Head, Early Development Oncology Capabilities & Alliances, Johnson & Johnson , Head , Early Development Oncology Capabilities & Alliances , Johnson & Johnson
Renee Smith, Head, Early Development Oncology Capabilities & Alliances, Johnson & Johnson , Head , Early Development Oncology Capabilities & Alliances , Johnson & Johnson

Panelists:

Photo of Jennifer Coppola, AVP Regional Head of North America, Global Clinical Trial Operations, Merck , AVP Regional Head of North America , Global Clinical Trial Operations , Merck
Jennifer Coppola, AVP Regional Head of North America, Global Clinical Trial Operations, Merck , AVP Regional Head of North America , Global Clinical Trial Operations , Merck
Photo of Philip Butera, Vice President, National Service Line, Oncology Clinical Trials , Vice President, National Service Line, Oncology Clinical Trials , Clinical Trials , Advocate Health
Philip Butera, Vice President, National Service Line, Oncology Clinical Trials , Vice President, National Service Line, Oncology Clinical Trials , Clinical Trials , Advocate Health
Photo of Nojan Namakian, Vice President, Strategic Partnerships, Alliance Management and Operations, City of Hope , Vice President, Strategic Partnerships & Alliance Management , Strategic Partnerships, Alliance Management and Operations , City of Hope Natl Medical Ctr
Nojan Namakian, Vice President, Strategic Partnerships, Alliance Management and Operations, City of Hope , Vice President, Strategic Partnerships & Alliance Management , Strategic Partnerships, Alliance Management and Operations , City of Hope Natl Medical Ctr

Panel Moderator:

PANEL DISCUSSION:
Where Distance Meets Discovery: Reimagining Rural Clinical Trial Delivery

Photo of Dixie D. Thompson, Director, Research & Science, University of Utah CTSI & the Trial Innovation Network, Vanderbilt , Director Research & Science , Clinical & Translational Science Institute , University of Utah
Dixie D. Thompson, Director, Research & Science, University of Utah CTSI & the Trial Innovation Network, Vanderbilt , Director Research & Science , Clinical & Translational Science Institute , University of Utah

Panelists:

Photo of J. Robinson Singleton, MD, Professor, Vice Chairman, Neurology, University of Utah , Professor, Vice Chairman , Neurology , University of Utah
J. Robinson Singleton, MD, Professor, Vice Chairman, Neurology, University of Utah , Professor, Vice Chairman , Neurology , University of Utah
Photo of Stacey Peterson, Research Manager, Clinical & Translational Science Institute, University of Utah , Research Manager , Clinical & Translational Science Institute , University of Utah
Stacey Peterson, Research Manager, Clinical & Translational Science Institute, University of Utah , Research Manager , Clinical & Translational Science Institute , University of Utah

Transition to Plenary Keynote

Wednesday Afternoon Plenary

WEDNESDAY PLENARY: THE DIGITAL TRANSFORMATION OF CLINICAL TRIALS

Organizer's Welcome Remarks

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: The Digital Transformation of Clinical Trials: From Protocol to Patient

Darren Weston, Head, Integrated Data Analytics and Reporting, Johnson & Johnson , Head , Integrated Data Analytics and Reporting , Johnson & Johnson

Panelists:

Michael Cantor, Vice President, Data Technology & Innovation, Regeneron Pharmaceuticals, Inc. , Vice President , Data Technology & Innovation , Regeneron Pharmaceuticals Inc

Justine Rochon, Senior Vice President, Head of R&D Data and Quantitative Sciences, Takeda , SVP , Head of R&D Data and Quantitative Sciences , Takeda

Sammi Rui Tang, PhD, Senior Vice President & Global Head, Quantitative Sciences & Evidence Generation, Astellas Pharma, Inc. , Sr VP & Global Head , Quantitative Sciences & Evidence Generation , Astellas Pharma Inc

Rachel Nering, Vice President, Head of Early Development and eDevelopment, Sanofi , VP , Head of Early Development and eDevelopment , Sanofi

SCOPE's Closing Booth Crawl (Sponsorship Opportunities Available) & Last Chance for Exhibit Viewing

One last trip through the Exhibit Hall! Join SCOPE's Booth Crawl for food, drinks, networking, and one final chance to explore the exhibits and connect with sponsors and colleagues. Be sure to visit your must-see booths and enter the raffle for a chance to win (must be present to win)-let's finish SCOPE strong!

Close of Day

SCOPE Out the Restaurants and Shops at Pointe Orlando, via Our Courtesy Shuttle* (Sponsorship Opportunities Available)

Enjoy an evening exploring the restaurants and shops at Pointe Orlando with transportation provided by our courtesy shuttle. Shuttles will run until 9:00 pm, with the last pick-up at 8:30 pm.

*Times subject to change. More details closer to the event.

Thursday, March 4

Registration Open

BREAKFAST PRESENTATION

Transition to Sessions

DRIVING TRIAL EFFICIENCY AND PATIENT IMPACT WITH DIGITAL TECHNOLOGIES

Presentation on eCOA Implementation Best Practices across Solution Design, Project Management, Data Management, and Vendor Management

Photo of Siva Bala, MBA, Senior Director, Clinical Data & Information Sciences, Pfizer Inc. , Sr Dir Clinical Data & Information Sciences , Clinical Data & Information Sciences , Pfizer Inc
Siva Bala, MBA, Senior Director, Clinical Data & Information Sciences, Pfizer Inc. , Sr Dir Clinical Data & Information Sciences , Clinical Data & Information Sciences , Pfizer Inc

To build a highly efficient, audit-ready electronic Clinical Outcome Assessments (eCOA) ecosystem, clinical teams must integrate clinical operational needs with technical software architectures. Pfizer has consolidated the best practices across the six core pillars of a comprehensive eCOA strategy, including patient-centric solution design; project management and operations; reporting, analytics and quality monitoring; software build cycle time optimization; data management and statistical lock; and vendor management and governance.

Panel Moderator:

PANEL DISCUSSION:
Driving Clinical Trial Efficiency with Digital Measures

Photo of Marissa Dockendorf, Executive Director, Head of Digital Clinical Measures, Merck & Co., Inc. , Executive Director , Digital Clinical Measures , Merck
Marissa Dockendorf, Executive Director, Head of Digital Clinical Measures, Merck & Co., Inc. , Executive Director , Digital Clinical Measures , Merck

Panelists:

Photo of Michelle Crouthamel, PhD, Head, Digital Sciences, AbbVie, Inc. , PhD, Head, Digital Sciences, AbbVie, Inc. , Digital Science , AbbVie Inc
Michelle Crouthamel, PhD, Head, Digital Sciences, AbbVie, Inc. , PhD, Head, Digital Sciences, AbbVie, Inc. , Digital Science , AbbVie Inc
Photo of Abhishek Pratap, PhD, Senior Clinical Program Leader, Central Nervous System, Boehringer Ingelheim , Sr Clinical Program Leader , Central Nervous System , Boehringer Ingelheim
Abhishek Pratap, PhD, Senior Clinical Program Leader, Central Nervous System, Boehringer Ingelheim , Sr Clinical Program Leader , Central Nervous System , Boehringer Ingelheim

Interactive Breakouts and Working Groups

INTERACTIVE WORKING GROUPS (IN-PERSON ONLY)

Find Your Working Group

Interactive Working Groups (Sponsorship Opportunity Available)

Step away from the slide decks and into the conversation.
After a full agenda of case studies, technical talks, and panels, SCOPE’s Interactive Working Groups offer a unique chance to roll up your sleeves and engage. Choose the topic that interests you—whether it aligns with your expertise or challenges you to think differently. Each group will explore a distinct theme using collaborative formats like hackathons, open innovation challenges, or problem-solving sprints. The only requirement: jump in and contribute.

Networking Coffee Break and Transition to Closing Keynote

Pause, connect, and get ready for the grand finale! Grab a cup of coffee, catch up with colleagues, and make a few final connections before heading into SCOPE’s Closing Keynote. It’s the perfect chance to recharge and refocus before we wrap up an incredible conference.

Closing Plenary Keynote

THURSDAY CLOSING PLENARY: REINVENTING R&D AND CLINICAL DEVELOPMENT

Organizer's Welcome Remarks

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

KEYNOTE PRESENTATION: Case Study: AI and the R&D Revolution: Reinventing Drug Development from Discovery to Clinical Trials

Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences , SVP Clinical Data Science , Clinical Data Science , Gilead Sciences

Dan Sheeran, Vice President & General Manager, Healthcare & Life Sciences, AWS , VP & GM Healthcare & Life , Healthcare & Life Sciences , AWS

AI is reshaping R&D from discovery through clinical development. This case study will explore how organizations are applying AI at scale to accelerate innovation, improve decision-making, and transform how new medicines are developed.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: The New Clinical Development Operating Model

Kristi Koontz, Vice President, Global Study and Site Operations, Amgen , VP , Global Study and Site Operations , Amgen

Panelists:

David Carruthers, Vice President, BioPharmaceuticals R&D Clinical Operations, AstraZeneca , Vice President , BioPharmaceuticals R&D Clinical Operations , AstraZeneca

Nick Hodges, Senior Vice President & Head, Clinical Development Operations & R&D Transformation Office, Ipsen , SVP, Head of Global Clinical Development , Global Clinical Operations , Ipsen

Henry Wei, MD, Executive Director, Development Innovation, Regeneron , Executive Director , Development Innovation , Regeneron Pharmaceuticals Inc

Community Luncheon and Last Hurrah

Wrap up SCOPE with closing remarks and lunch, courtesy of our sponsors! Enjoy your lunch here with us or grab it to go as you head out for the day. The poolside is calling.

Wrap up SCOPE with Closing Remarks and Lunch, Courtesy of Our Sponsors!

That’s a wrap! Thank you for joining us at SCOPE Summit 2027. We hope you leave inspired, connected, and energized by the conversations and ideas shared throughout the week. Safe travels, and we look forward to seeing you at the next SCOPE event!

Scope Summit 2027 Adjourns

#SCOPEsummit
SCOPE Track Summariese
SCOE Europe
SCOE Europe
Coming Soon - SCOPE X
SCOPE 365 ClinEco Connect
SCOPE of Things Podcast
Participant Engagement Award
Best of Show Award
Site Innovation Award
Join SCOPE LinkedIn Group
Event at a Glance
Media Partners
Attendee List
attendee profile

2027 Conference Programs

TRIAL DESIGN & PROTOCOL OPTIMIZATION

◆ Patient and Site Voice in Protocol Design

◆ Technology, Data and AI/ML for Intelligent Trial Design

FEASIBILITY & SITE STRATEGY

◆ Data-Driven Feasibility and Investigator Selection

◆ Tech and Collaboration to Streamline Start-Up and Reduce Site Burden

RECRUITMENT & ENGAGEMENT

◆ Enrollment Strategy and Trial Readiness

◆ Access, Trust, and Participant Engagement

SITE PARTNERING & OPERATIONS

◆ Building Strategic Sponsor-Site Partnerships

◆ Tech and Collaboration to Streamline Start-Up and Reduce Site Burden

BUDGETING & RESOURCES

◆ Clinical Trial Budgeting, Contracting, and Payments

◆ Clinical Trial Resource Management and Operational Planning

OUTSOURCING

◆ Mastering an Outsourcing Strategy

◆ Relationship and Alliance Management in Outsourced Clinical Trials

SCOPE BIOTECH FORUM

◆ Building Early-Stage Study Infrastructure

◆ Scaling Clinical Capabilities for Late-Stage Development

DATA

◆ Clinical Data Strategy

◆ Integrating AI into Clinical Data and Analytics

ADVANCING TRIAL DELIVERY

◆ Operational Excellence in Trial Execution

◆ Point-of-Care, Remote, and Decentralized Models

DIGITAL MEASURES & eCLINICAL TECHNOLOGIES

◆ Digital Endpoints and Biomarkers

◆ Digital Trials in a Connected Health Ecosystem

REAL WORLD EVIDENCE

◆ Accessing and Generating RWD

◆ Leveraging RWD for Clinical Research

AI IN CLINICAL RESEARCH

◆ Agentic AI in Clinical Research

◆ AI for Trial Optimization and Data Management

QUALITY & MONITORING

◆ Risk-Based Quality Management

◆ Central Monitoring and Signal Detection

SAFETY & PHARMACOVIGILANCE

◆ Building a Unified Safety Ecosystem

◆ Next-Generation Technologies and Intelligent Signal Detection

BIOSPECIMEN STRATEGY & OPERATIONS

◆ Modernizing Lab, Biospecimen & Data Management Operations

◆ Biomarker & Biospecimen Technology & Innovation

CLINICAL SUPPLY & LOGISTICS

◆ Communication & Digitization for End-to-End Clinical Supply Management

◆ Clinical Supply Chain Strategies to Align Process, Products, and Patients

THERAPEUTIC AREA SPOTLIGHTS

◆ CNS & Mental Health Trials

◆ Metabolic & Obesity Trials

◆ Oncology Trials

◆ Immunology & Inflammation Trials

INVESTOR CONFERENCE

◆ Clinical Trial Venture, Innovation & Partnering

PRE-CON EVENTS

◆ Monday Golf,  Opening Keynote with Site Innovation Awards & Participant Engagement Award

◆ SCOPE’s Opening Reception

◆ Pre-Con User Group & Workshops